AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on March 20, 2008
doi: 10.3174/ajnr.A0928

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A0928v1
29/6/1036    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Bartynski, W.S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartynski, W.S.

Review Article

Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features

W.S. Bartynskia

a From the Department of Radiology, Division of Neuroradiology, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, Pa

Please address correspondence to Walter S. Bartynski, MD, Department of Radiology, Division of Neuroradiology, University of Pittsburgh, Presbyterian University Hospital, 200 Lothrop St, D 132, Pittsburgh PA 15213; e-mail: bartynskiws{at}upmc.edu

SUMMARY: Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic state coupled with a unique CT or MR imaging appearance. Recognized in the setting of a number of complex conditions (preeclampsia/eclampsia, allogeneic bone marrow transplantation, organ transplantation, autoimmune disease and high dose chemotherapy) the imaging, clinical and laboratory features of this toxic state are becoming better elucidated. This review summarizes the basic and advanced imaging features of PRES, along with pertinent features of the clinical and laboratory presentation and available histopathology. Many common imaging/clinical/laboratory observations are present among these patients, despite the perception of widely different associated clinical conditions.